Navigation Links
Derma Sciences Launches Two New MEDIHONEY(TM) Formulations
Date:6/26/2008

Additional products will provide coverage for most wound types

PRINCETON, N.J., June 26 /PRNewswire-FirstCall/ -- Derma Sciences (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that it is launching two new formulations of its key product line, MEDIHONEY(TM) Wound & Burn Dressings, this week. The new products consist of 100 percent Active Leptospermum Honey packaged in a tube, and a patented colloidal sheet referred to as a Honeycolloid(TM). These two new formulations will greatly enhance the brand's utilization in variety of wounds, including lightly draining wounds, wounds that are difficult to dress due to their anatomical location, and wounds on patients that are sensitive to pain at dressing changes.

CEO Ed Quilty stated, "We are very excited about these two new products hitting the market. Our customers have been requesting a MEDIHONEY version dispensed from a tube. This will help them to reach and dress difficult areas. It also provides a dressing to be used when the wound is not draining. The Honeycolloid is based on one of the patents we licensed from our global commercialization partner, Comvita New Zealand, Inc. This dressing is the most sophisticated in the line, combining ease-of-use attributes with strong clinical benefits. The Leptospermum honey is intrinsically bound within the dressing, allowing the honey to stay at the site of the wound longer even in the presence of exudate. This is a key challenge with honey based dressings used on exudating wounds. Additionally, although decreasing the pH of a wound has been proven to have significant healing benefits, quickly reducing the pH of a wound can cause slight transient stinging in a small percentage of patients. This happens with several popular wound care products including enzymatic debriding agents and honey-based dressings. With the Honeycolloid formulation, even though it is comprised of 80 percent honey, the pH modulation takes a longer amount of time, thus reducing the chance of any transient stinging. For patients with painful leg ulcers, this will be a real benefit.

"We have already come a very long way in establishing MEDIHONEY as a strong up-and-coming brand in the United States and Canada" Quilty added. This week's Wound Ostomy and Continence Nursing annual conference held in Orlando was a huge success for Derma Sciences. Awareness of the brand is very strong among clinicians, and we should see a spike in an already impressive rate of clinical evaluations. The addition of these new formulations, especially the patented Honeycolloid dressing, adds to the brand and further distances us from any other potential competitors."

All major distributor customers have loaded the new products into their information systems, and sales to them will begin immediately.

About Derma Sciences

Derma Sciences is a global manufacturer and marketer of advanced wound-care products. Its key product, MEDIHONEY, is sold throughout the world by Derma Sciences and Comvita New Zealand -- the licensor of the patented honey-based technology -- and is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of wounds and burns, and was recently the focus of a large-scale randomized controlled trial on leg ulcers. Derma has two products in development: the BIOGUARD(TM) line of barrier gauze dressings, and DSC127, the company's novel angiotensin analog for accelerated wound healing and scar reduction. The barrier technology was licensed from Quick-Med in Q1 of 2007 and is pending its initial FDA marketing clearance. DSC127 was licensed from The University of Southern California in Q4 of 2007 and is entering into a Phase II study, with anticipated initial patient enrollment to begin in Q3 of 2008. For more information about Derma Sciences, Inc., visit its home page on the Internet at http://www.dermasciences.com.

Contact: Derma Sciences Inc Allen & Caron Inc

Edward J. Quilty Rudy Barrio (Investors)

Chairman and CEO r.barrio@allencaron.com

equilty@dermasciences.com

(609) 514-4744 Brian Kennedy (media)

brian@allencaron.com

(212) 691-8087


'/>"/>
SOURCE Derma Sciences
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
2. Dermatologists identify North Texas leishmaniasis outbreak
3. Tissue-Growth Gene Tied to Scleroderma
4. American Academy of Dermatology Association Commends President Bush for Signing Tanning Accountability and Notification (TAN) Act
5. UltraShape(TM) Non-Invasive Fat Reduction and Body Contouring Clinical Study Results Presented at American Society for Dermatologic Surgery Annual Meeting
6. VivaScope(R) Confocal Imager May Eliminate Need for Routine Skin Biopsies for Dermatology Patients
7. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
8. American Academy of Dermatology: New Study Finds Women More Likely Than Men to be Affected by Acne as Adults
9. New Study Provides Scientific Evidence That DermaLastyl Face Cream Reduces Wrinkles
10. Dermatologists Warn Fitness Enthusiasts: Dont Let Exercise-Related Skin Problems Outweigh the Benefits of Physical Activity
11. Active compounds found in Ganoderma lucidum fungus with potential to treat prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... Southland Log Homes , ... American timber frame barn kits, which can be found on its website at SouthlandLogHomes.com. ... American barn plans, and they highlight the craftsmanship of timber post and beam construction. ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent ... the demand for a sustainable product to aid in the rehabilitation process has steadily ... the recovery of individuals with hemiplegia due to stroke. , Ekso Bionics has now ...
(Date:5/27/2016)... ... ... Beleza Medspa has initiated a new program to assist active ... time that Coolsculpting is being used for for more than just cosmetic purposes. ... the prescribed body-fat standard, measured by the circumference-based tape method. The tape-test is ...
(Date:5/27/2016)... ... ... With a team of certified experts, Validation Center is ... GMP accreditation, Validation Center is also a registered authority of the international system ... Validation Center is ISO17025 accredited and only offers its clients the latest technology, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot ... of defective respirators, according to court documents and SEC filings. A jury ... Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... May 25, 2016 As illustrated ... earlier this month, the numbers and momentum of cannabis ... climb into the billions, more research and development push ... Edition State of Legal Marijuana Markets Report  from from ... firm, much of the increase in sector is attributed ...
(Date:5/25/2016)... 25, 2016 ReportsnReports.com adds ... report that provides an overview on therapeutic pipeline ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Chronic ...
(Date:5/24/2016)...  Diana Russell suffers from a form of rheumatoid ... out.  This disease has put her in a wheelchair, ... grandchildren to leave her home.  Because of the size ... the wheelchair.  So if there is a family function, ... left to wait for the bus. Photo ...
Breaking Medicine Technology: